Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home OCT-Guided Management of Neovascular Age Related Macular Degeneration: Outcomes and Insight After Switch to Faricimab for One Year

NCT07744984 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT07744984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07744984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home OCT-Guided Management of Neovascular Age Related Macular Degeneration: Outcomes and Insight After Switch to Faricimab for One Year
Lead sponsor
Rabin Medical Center
Phase
Observational
Overall status
Completed
Start date
July 3, 2024
Completion date
July 1, 2026
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration (amd), neovascular age-related macular degeneration (namd) wet amd